John Higgins, Ligand Pharmaceuticals CEO, joins 'Power Lunch' to discuss how the company's drug discovery technology is helping with the race to find a cure for the coronavirus.
John Higgins, Ligand Pharmaceuticals CEO, joins 'Power Lunch' to discuss how the company's drug discovery technology is helping with the race to find a cure for the coronavirus.
0 Comments